Updated on 9 September 2013
Through this research collaboration, NCIS aims to find better ways to screen, diagnose and treat cancer. Today, cancer research and education efforts on campus are spearheaded by NCIS and CSI. This partnership will enable clinicians and scientists to work on high quality research projects and develop new therapeutic strategies which will benefit Asian patients.
"The establishment of KHK's STRL is an excellent example of companies leveraging Singapore's translational and clinical research ecosystem to accelerate the drug discovery and development process. We are delighted that KHK has chosen to work with Singapore, and we will continue to enhance our infrastructure and capabilities to enable companies to conduct translational research", said Mr Kevin Lai, director Biomedical Sciences, Singapore Economic Development Board.